Researchers at Harvard University developed an effective personalized cancer vaccine that seems to have prevented early tumour relapse in 12 skin cancer patients. The vaccine targeted 20 tumour-specific proteins unique to each of the patients enrolled, keeping all free of cancer over 2 years after the trial.
A group of US researchers proposed a cutting edge alternative for eliminating resilient bacteria in the form of a “CRISPR pill”. The drug can specifically target harmful bugs using a combination of bacteria-seeking viruses and a cocktail of probiotics, making it more potent than most antibiotics.
Researchers from Harvard University announced their plan to bring the woolly mammoth back to life using CRISPR/Cas9 within two years’ time. This would not only allow us to learn more about the prehistoric behemoth, but would also represent a first step towards preservation of endangered species.
While labs are facing growing amounts of data, solutions are opening up on the global scene to help them cope with it. The change is already here. And it might be better than we expected.
The social phenomenon of procrastination is steadily becoming a topic of increasing discussion in various fields of science. Although approaches for studying it differ greatly, researchers agree it is not doing our society any favors. But might unraveling its mysteries finally help us overcome it?
Isn´t the sensation of being tickled just the most bizarre? As silly as it might seem, there is apparently a whole evolutionary war being waged in the process of tickling, according to studies.
A thrilling report has surfaced about the first baby being born as a result of a controversial fertilization technique, the spindle nuclear transfer. The procedure incorporates DNA from three “biological parents” to serve as the embryo’s genomic base, and is used to prevent mitochondrial diseases in infants.
There are people living among us, with capabilities we could easily call superpowers, and in most cases, they are not even aware of it. It turns out a tiny percentage of women actually develop a genetic condition called “tetrachromacy“, enabling them to see the world in hundred times more colors than the rest of us.
A thrilling new approach has been developed for targeted gene therapy that brought a cloud of excitement over the scientific community. You might have guessed it – the delivery of vaporized gene vectors to battle cystic fibrosis.